Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Adamis Pharmaceuticals Corp    ADMP

ADAMIS PHARMACEUTICALS CORP

(ADMP)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector news

ADAMIS PHARMACEUTICALS CORP : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/10/2018 | 04:19pm EDT

Item 2.02 Results of Operations and Financial Conditions

On August 10, 2018, Adamis Pharmaceuticals Corporation (the "Company") issued a press release announcing certain financial information for the quarter ended June 30, 2018. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information furnished in this Form 8-K and the press release attached as Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits




(d) Exhibits.


Exhibit No. Exhibit Description

99.1 Press release dated August 10, 2018

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ADAMIS PHARMACEUTICALS COR
06:44aADAMIS PHARMACEUTICALS : Announces Patent Litigation Regarding Its Higher Dose N..
AQ
05/21ADAMIS PHARMACEUTICALS CORP : Other Events (form 8-K)
AQ
05/21ADAMIS PHARMACEUTICALS : Announces Patent Litigation Regarding Its Higher Dose N..
AQ
05/15ADAMIS PHARMACEUTICALS : Announces Conditional Acceptance by FDA of Proprietary ..
AQ
05/14Adamis Pharmaceuticals Announces Conditional Acceptance by FDA of Proprietary..
GL
05/09ADAMIS PHARMACEUTICALS CORP : Results of Operations and Financial Condition (for..
AQ
05/09ADAMIS : 1Q Earnings Snapshot
AQ
05/09ADAMIS PHARMACEUTICALS : Announces First Quarter 2019 Financial Results and Busi..
AQ
05/09ADAMIS PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condi..
AQ
05/07Adamis Pharmaceuticals Schedules First Quarter 2019 Earnings Conference Call ..
GL
More news
Financials ($)
Sales 2019 23,0 M
EBIT 2019 -31,3 M
Net income 2019 -27,6 M
Debt 2019 -
Yield 2019 -
P/E ratio 2019 -
P/E ratio 2020
Capi. / Sales 2019 3,75x
Capi. / Sales 2020 2,45x
Capitalization 86,3 M
Chart ADAMIS PHARMACEUTICALS CORP
Duration : Period :
Adamis Pharmaceuticals Corp Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ADAMIS PHARMACEUTICALS COR
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 5,30 $
Spread / Average Target 191%
EPS Revisions
Managers
NameTitle
Dennis J. Carlo President, Chief Executive Officer & Director
Richard C. Williams Chairman
Karen K. Daniels Vice President-Operations
Robert O. Hopkins Chief Financial Officer, Secretary & VP-Finance
Thomas H. Moll Vice President-Research
Sector and Competitors
1st jan.Capitalization (M$)
ADAMIS PHARMACEUTICALS CORP-28.89%86
JOHNSON & JOHNSON7.26%367 513
PFIZER-4.72%231 237
ROCHE HOLDING LTD.9.70%226 519
NOVARTIS12.54%207 417
MERCK AND COMPANY4.04%203 088